Low expression of TS, as evaluated by immunohistochemistry and reverse-transcription PCR (RT-PCR), correlated with a favorable response to 5-FU-based therapy in colorectal cancer patients [25, 28, 29]. The gene discussed is TYMS; the disease is colorectal cancer.